Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2003-1-8
pubmed:abstractText
Suppressor of cytokine signaling (SOCS)-1 is a member of a family of proteins that negatively regulate cytokine signaling pathways. We have previously established that SOCS-1 is a key regulator of IFN-gamma signaling and that IFN-gamma is responsible for the complex inflammatory disease that leads to the death of SOCS-1-deficient mice. In this study, we provide evidence that SOCS-1 is also a critical regulator of IFN-gamma-independent immunoregulatory factors. Mice lacking both SOCS-1 and IFN-gamma, although outwardly healthy, have clear abnormalities in their immune system, including a reduced ratio of CD4:CD8 T cells in lymphoid tissues and increased expression of T cell activation markers. To examine the contribution of TCR Ag specificity to these immune defects, we have generated two lines of SOCS-1-deficient mice expressing a transgenic TCR specific for an exogenous Ag, OVA (OT-I and OT-II). Although TCR transgenic SOCS-1(-/-) mice have a longer lifespan than nontransgenic SOCS-1(-/-) mice, they still die as young adults with inflammatory disease and the TCR transgenic SOCS-1(-/-) T cells appear activated despite the absence of OVA. This suggests that both Ag-dependent and -independent mechanisms contribute to the disease in SOCS-1-deficient mice. Thus, SOCS-1 is a critical regulator of T cell activation and homeostasis, and its influence extends beyond regulating IFN-gamma signaling.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
170
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
878-86
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:12517953-Animals, pubmed-meshheading:12517953-CD4-CD8 Ratio, pubmed-meshheading:12517953-Carrier Proteins, pubmed-meshheading:12517953-Cytokines, pubmed-meshheading:12517953-Epitopes, T-Lymphocyte, pubmed-meshheading:12517953-Fetus, pubmed-meshheading:12517953-Homeostasis, pubmed-meshheading:12517953-Immunophenotyping, pubmed-meshheading:12517953-Interferon-gamma, pubmed-meshheading:12517953-Lymphatic Diseases, pubmed-meshheading:12517953-Lymphocyte Activation, pubmed-meshheading:12517953-Mice, pubmed-meshheading:12517953-Mice, Inbred BALB C, pubmed-meshheading:12517953-Mice, Inbred C57BL, pubmed-meshheading:12517953-Mice, Knockout, pubmed-meshheading:12517953-Mice, Transgenic, pubmed-meshheading:12517953-Organ Culture Techniques, pubmed-meshheading:12517953-Receptors, Antigen, T-Cell, pubmed-meshheading:12517953-Repressor Proteins, pubmed-meshheading:12517953-Signal Transduction, pubmed-meshheading:12517953-Suppressor of Cytokine Signaling Proteins, pubmed-meshheading:12517953-T-Lymphocyte Subsets, pubmed-meshheading:12517953-Thymus Gland
pubmed:year
2003
pubmed:articleTitle
Suppressor of cytokine signaling-1 has IFN-gamma-independent actions in T cell homeostasis.
pubmed:affiliation
The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't